| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 12/31/2008 | WO2008061157A3 Generation of plants with altered protein, fiber, or oil content |
| 12/31/2008 | WO2008057961A3 Compositions and methods for the detection of trypanosoma cruzi infection |
| 12/31/2008 | WO2008013914A3 Compositions and methods for diagnosing patients with acute atherosclerotic syndromes |
| 12/31/2008 | WO2007140474A3 Compositions and methods for detection and modulation of t cell mediated immune responses against viral vectors utilized for gene therapy |
| 12/31/2008 | WO2007119011A9 N protein fusion proteins of a virus in the paramyxoviridae-protein of interest family |
| 12/31/2008 | WO2007119011A8 N protein fusion proteins of a virus in the paramyxoviridae-protein of interest family |
| 12/31/2008 | WO2007105218A3 Composition and method for brain tumor therapy |
| 12/31/2008 | WO2007087420A3 Production of proteins carrying oligomannose or human-like glycans in yeast and methods of use thereof |
| 12/31/2008 | WO2007075933A3 Translocation and mutant csf1r kinase in human leukemia |
| 12/31/2008 | WO2007047985A3 Trpm5 based assays and the use thereof for the identification of modulators of sweet, bitter or umami (savory) taste |
| 12/31/2008 | EP2009445A1 Use of a camelid single-domain antibody for detecting an oligomeric form of an amyloid beta peptide and its applications |
| 12/31/2008 | EP2009117A2 Method for diagnosing pancreatic cancer |
| 12/31/2008 | EP2009109A1 G protein-related kinase mutants in essential hypertension |
| 12/31/2008 | EP2009105A1 Novel serotype Streptococcus mutans and utilization of the same |
| 12/31/2008 | EP2009104A1 Phosphorylation epitopes of Tau protein for the diagnosis and treatment of Alzheimer's disease |
| 12/31/2008 | EP2009103A1 Neurotrophic peptides |
| 12/31/2008 | EP2009025A1 Method of inhibiting osteoclast activity |
| 12/31/2008 | EP2009024A1 Glucagon-like peptide-2 analogs |
| 12/31/2008 | EP2009023A1 Novel peptides and their use for the treatment of edema |
| 12/31/2008 | EP2009022A1 Trimeric death ligands with enhanced activity (tenascin) |
| 12/31/2008 | EP2009021A1 DNA molecules encoding ligand gated ion channels from dermacentor variabilis |
| 12/31/2008 | EP2009020A2 Means and methods to modulate flavonoid biosynthesis in plants and plant cells |
| 12/31/2008 | EP2009019A1 P53 binding T cell receptor molecules and uses thereof |
| 12/31/2008 | EP2009018A2 T cell antigen receptor peptides |
| 12/31/2008 | EP2008664A2 Modified proteins which bind extracellular matrix components |
| 12/31/2008 | EP2008106A2 Methods of determining cellular chemosensitivity |
| 12/31/2008 | EP2008095A1 Functional method to identify tastants |
| 12/31/2008 | EP2007911A2 Soluble virus-specific t-cell receptor compositions |
| 12/31/2008 | EP2007894A2 Method for modifying the atp/adp ratio in cells |
| 12/31/2008 | EP2007815A2 Mono- and bifunctional molecules with ability to bind to g protein-coupled receptors |
| 12/31/2008 | EP2007807A2 Composition and method for mediating an immune response |
| 12/31/2008 | EP2007806A2 Tetramerizing polypeptides and methods of use |
| 12/31/2008 | EP2007805A1 Nucleic acid, polypeptide and its use |
| 12/31/2008 | EP2007804A2 Glp-1 compounds |
| 12/31/2008 | EP2007802A1 Fusion proteins comprising alpha fetoprotein |
| 12/31/2008 | EP2007801A1 Binder for c-reactive protein |
| 12/31/2008 | EP2007800A1 Methods of binding of cross-beta structures by chaperones |
| 12/31/2008 | EP2007799A2 Isolated polynucleotide molecules corresponding to mutant and wild-type alleles of the maize d9 gene and methods of use |
| 12/31/2008 | EP2007798A1 Hypoallergenic chimeric proteins belonging to the lipid transfer family of parietaria judaica for use in the treatment of allergies |
| 12/31/2008 | EP2007797A2 Variants of the chemotaxis inhibitory protein of staphylococcus aureus |
| 12/31/2008 | EP2007796A2 Use of staphylococcal superantigen-like protein 5 (ssl5) in medicine |
| 12/31/2008 | EP2007795A2 Aav capsid library and aav capsid proteins |
| 12/31/2008 | EP2007425A2 Methods for treating conditions associated with masp-2 dependent complement activation |
| 12/31/2008 | EP2007420A2 Recombinant attenuated clostridium organisms and vaccine |
| 12/31/2008 | EP2007417A1 Covalent factor vii-tissue factor complex |
| 12/31/2008 | EP2007364A1 Transcription factor modulator |
| 12/31/2008 | EP2007195A1 Animal model based on targeted apoptosis for the study of genetic diseases such as parkinson's disease |
| 12/31/2008 | EP1824882A4 Osteoprotegerin variant proteins |
| 12/31/2008 | EP1817333A4 Canine cholecystokinin 1 receptor materials and their use |
| 12/31/2008 | EP1773872A4 Variable lymphocyte receptors, related polypeptides and nucleic acids, and uses thereof |
| 12/31/2008 | EP1758924B1 Peptides antagonists for inhibiting heat shock protein (hsp 16.3) of mycobacterium tuberculosis |
| 12/31/2008 | EP1750773B1 Drugs for the prevention or treatment of immunodeficiencies, autoimmune diseases or for the induction of immune tolerance |
| 12/31/2008 | EP1737955B1 Novel temperature regulated promoters and expression vectors from s.pombe |
| 12/31/2008 | EP1718760B1 Protein phosphorylation in c-src signaling pathways |
| 12/31/2008 | EP1718323A4 Binding peptidomimetics and uses of the same |
| 12/31/2008 | EP1682666B1 HIV Pharmaceutical vaccines |
| 12/31/2008 | EP1664095B1 Antimicrobial polypeptides |
| 12/31/2008 | EP1640454B1 Cd9/cd81 double-deficient non-human animal |
| 12/31/2008 | EP1579212B1 Methods of identifying reduced internalization transmembrane receptor agonists |
| 12/31/2008 | EP1556518B1 Genes and polypeptides relating to human pancreatic cancers |
| 12/31/2008 | EP1550457B1 Vaccine composition comprising interleukin-15 (il-15) |
| 12/31/2008 | EP1549771B1 Method for diagnosing pancreatic cancer |
| 12/31/2008 | EP1539794B1 Benzoate- and anthranilate-inducible promoters |
| 12/31/2008 | EP1534829B1 Use of a Picramnia pentandra defensin for enhancing plant resistance against nematodes |
| 12/31/2008 | EP1512744B1 Pigment protein |
| 12/31/2008 | EP1448760B1 Methods for monitoring polypeptide production and purification using surface enhanced laser desorption/ionization mass spectrometry |
| 12/31/2008 | EP1443960B1 Antigen arrays presenting il-5, il-13 or eotaxin for treatment of allergic eosinophilic diseases |
| 12/31/2008 | EP1412503B1 A fusion protein |
| 12/31/2008 | EP1392106B1 Tyra genes and uses thereof |
| 12/31/2008 | EP1350085B1 Monoclonal antibodies and cell surface antigens for the detection and treatment of small cell lung cancer (sclc) |
| 12/31/2008 | EP1333871B1 Hydrophobic multicomponent heparin conjugates, a preparing method and a use thereof |
| 12/31/2008 | EP1328628B1 Method for exposing peptides and polypeptides on the cell surface of bacteria |
| 12/31/2008 | EP1309610B1 Peptide and peptide mimetic derivatives with integrin inhibitor properties ii |
| 12/31/2008 | EP1305039B1 Stable (fixed) forms of viral l1 capsid proteins, fusion proteins and uses thereof |
| 12/31/2008 | EP1294879B1 Thymic stromal lymphopoietin receptor molecules and uses thereof |
| 12/31/2008 | EP1294872B1 Human trp-like calcium channel protein-2 (tlcc-2) |
| 12/31/2008 | EP1287152B1 Human-bovine chimeric respiratory syncytial virus vaccines |
| 12/31/2008 | EP1268761B1 Human urothelial cell specific uroplakin transcriptional regulatory sequences, vectors comprising the same, and methods of use thereof |
| 12/31/2008 | EP1268525B1 Macrocyclic ns3-serine protease inhibitors of hepatitis c virus comprising n-cyclic p2 moieties |
| 12/31/2008 | EP1251731B1 Protein kinase stress-related proteins and methods of use in plants |
| 12/31/2008 | EP1235073B1 cGMP-VISUALIZING PROBE AND METHOD OF DETECTING AND QUANTIFYING cGMP BY USING THE SAME |
| 12/31/2008 | EP1203239B1 Use of a polypeptide for detecting a pathological condition associated with multiple sclerosis |
| 12/31/2008 | EP1192260B1 Arabidopsis thaliana cdc27 homologs |
| 12/31/2008 | EP1113810B1 Methods of treating multiple myeloma and myeloma-induced bone resorption using antagonists of integrin / receptor binding |
| 12/31/2008 | EP1032672B1 Dna19355 polypeptide, a tumor necrosis factor homolog |
| 12/31/2008 | EP0991769B1 A method for plant protection against insects or nematodes |
| 12/31/2008 | EP0989863B1 System for the in vivo delivery and expression of heterologous genes in the bone marrow |
| 12/31/2008 | EP0964873B1 Use of glucagon-like peptide-1 (glp-1) or analogs to abolish catabolic changes after surgery |
| 12/31/2008 | EP0912730B1 Conjugates of soluble peptidic compounds with membrane-binding agents |
| 12/31/2008 | EP0759937B2 Peptides for inducing cytotoxic t lymphocyte responses to hepatitis c virus |
| 12/31/2008 | CN101336252A Recombinant production of heparin binding proteins |
| 12/31/2008 | CN101336251A Neuregulin variants and methods of screening and using thereof |
| 12/31/2008 | CN101336250A Polypeptides |
| 12/31/2008 | CN101334356A Gas sensors |
| 12/31/2008 | CN101333540A Photosynthetic bacteria expression system capable rapidly detecting exogenous protein expression and use thereof |
| 12/31/2008 | CN101333535A Plant with improved organogenesis and method of constructing the same |
| 12/31/2008 | CN101333533A Temperature sensing male fertile gene and use thereof |
| 12/31/2008 | CN101333531A CXCR4 antagonist recombination protein SDF-1 beta P2G, preparation method and application thereof |
| 12/31/2008 | CN101333259A Preparation of <99m>Tc galactosyl human serum albumin fusion interferon of liver receptor developer and uses thereof |
| 12/31/2008 | CN101333252A Decorin gene capable of restraining tumour cell from growing and transferring, preparation method and application thereof |